Li Anqi, Li Gongduan, Han Dong, Fu Manru, Chang Jinghui
School of Health Management, Southern Medical University, Guangzhou, China.
Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Front Public Health. 2025 Jan 9;12:1468606. doi: 10.3389/fpubh.2024.1468606. eCollection 2024.
This study aims to explore the impact of the National Volume-based Procurement Policy in Guangdong Province on hospitalization costs for total knee arthroplasty inpatients.
Interrupted time-series analysis were used to examine the expenses associated with total knee arthroplasty for inpatients at a hospital in Guangzhou between May 10, 2021, and December 26, 2023. The period was divided into two phases based on the implementation of the policy, the pre-policy phase (May 10, 2021, to April 30, 2022) and the post-policy phase (May 1, 2022, to December 26, 2023). A total of ten indicators, derived from patients' medical records, were analyzed. Indicators included total expenses, self-financed expenses, consumables costs, miscellaneous service fees, diagnostic fees, treatment fees, rehabilitation fees, total Chinese medicine costs, western medicine costs, and the costs of blood and blood products.
A total of 1,196 valid cases were included, with 290 cases before policy implementation and 906 cases after implementation. When the implementation of procurement occurred (May 1, 2022), total expenses ( - 28240.17, < 0.001), consumables costs ( - 31302.72, < 0.001), and self-financed expenses ( - 13674.56, <0.001) showed an instantaneous decreasing trend. The mean total expenses decreased from 65,324.73 CNY per case to 34,465.57 CNY per case, representing a reduction of 30,859.16 CNY per case. Miscellaneous service fees ( = 440.45, < 0.05), diagnostic fees ( =746.00, < 0.05), rehabilitation fees ( =207.36, < 0.001) exhibited an instantaneous and slight increasing trend. After implementation (from May 1, 2022 to December 26, 2023), the total expenses ( 106.95, <0.05), consumables costs ( - 65.05, <0.05), diagnostic fees ( - 22.44, < 0.05), treatment fees ( - 28.01, < 0.05), total Chinese medicine costs ( - 9.98, < 0.05), and blood and blood products costs ( - 5.88, <0.05) continued to decrease.
The volume-based procurement policy in Guangdong, China has shown initial effectiveness. After it was implemented, total expenses, consumables costs, and self-financed expenses decreased. The structure of hospitalization costs also reflects the slight improvement in healthcare providers' value and treatment planning decisions. Further attention should be given to the healthcare professionals' labor value. The empirical analysis results provide a reference for the government further to improve the volume-based procurement for artificial joints.
本研究旨在探讨广东省国家集采政策对全膝关节置换术住院患者住院费用的影响。
采用中断时间序列分析方法,对广州市某医院2021年5月10日至2023年12月26日期间全膝关节置换术住院患者的费用进行研究。根据政策实施情况将研究期间分为两个阶段,政策实施前阶段(2021年5月10日至2022年4月30日)和政策实施后阶段(2022年5月1日至2023年12月26日)。从患者病历中提取共十个指标进行分析。指标包括总费用、自费费用、耗材成本、杂项服务费、诊断费、治疗费、康复费、中药总费用、西药费用以及血液及血液制品费用。
共纳入1196例有效病例,其中政策实施前290例,实施后906例。在集采政策实施时(2022年5月1日),总费用(β=-28240.17,P<0.001)、耗材成本(β=-31302.72,P<0.001)和自费费用(β=-13674.56,P<0.001)呈现瞬时下降趋势。平均总费用从每例65324.73元降至每例34465.57元,每例减少30859.16元。杂项服务费(β=440.45,P<0.05)、诊断费(β=746.00,P<0.05)、康复费(β=207.36,P<0.001)呈现瞬时轻微上升趋势。政策实施后(2022年5月1日至2023年12月26日),总费用(β=106.95,P<0.05)、耗材成本(β=-65.05,P<0.05)、诊断费(β=-22.44,P<0.05)、治疗费(β=-28.01,P<0.05)、中药总费用(β=-9.98,P<0.05)以及血液及血液制品费用(β=-5.88,P<0.05)继续下降。
中国广东省的集采政策已初见成效。政策实施后,总费用、耗材成本和自费费用均有所下降。住院费用结构也反映出医疗服务提供者在价值和治疗规划决策方面略有改善。应进一步关注医护人员的劳动价值。实证分析结果为政府进一步完善人工关节集采提供了参考。